Biotechnology policy in European countries: An assessment
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
ABSTRACT: For more than 20 years, all major European governments have put biotechnology as a priority on their innovation policy agendas. How did each of the three big countries – France, the UK and Germany – manage their biotechnology policy, and what results have they achieved? A project funded by the European Commission tried to find out by assessing, over the period 1994–2001, the development of the knowledge base, patent activities, technology transfer measures, regulatory policy, industry promotion measure and public opinion...
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
For more information, see the Journal of Commercial Biotechnology website
Comments are closed.